We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease.
- Authors
Elhassan, Nahed O; Sorbero, Melony E S; Hall, Caroline B; Stevens, Timothy P; Dick, Andrew W
- Abstract
To evaluate the cost-effectiveness of palivizumab as respiratory syncytial virus prophylaxis in premature infants without chronic lung disease and to evaluate the impact on cost-effectiveness of a potential reduction in risk of asthma following respiratory syncytial virus infection among infants receiving palivizumab.
- Publication
Archives of pediatrics & adolescent medicine, 2006, Vol 160, Issue 10, p1070
- ISSN
1072-4710
- Publication type
Journal Article
- DOI
10.1001/archpedi.160.10.1070